Precision BioSciences IncNASDAQ:DTIL
- LAST PRICE6.5000
- TODAY'S CHANGE (%)-0.6800 (-9.4708%)
- Bid / Lots6.5900/ 1
- Ask / Lots6.8800/ 4
- Open / Previous Close7.0700 / 7.1800
- Day Range
- 52 Week Range
- Volume224,751
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DTIL |
|---|---|---|
| 09:32 ET | 12741 | 7.07 |
| 09:33 ET | 816 | 7.0749 |
| 09:35 ET | 530 | 7.08 |
| 09:37 ET | 2500 | 7.12 |
| 09:39 ET | 1654 | 7.0801 |
| 09:42 ET | 11000 | 7 |
| 09:44 ET | 932 | 6.99 |
| 09:46 ET | 4400 | 6.9556 |
| 09:50 ET | 1080 | 6.95 |
| 09:51 ET | 100 | 6.97 |
| 09:53 ET | 400 | 6.945 |
| 09:55 ET | 100 | 6.92 |
| 09:57 ET | 1796 | 6.89 |
| 10:00 ET | 100 | 6.88 |
| 10:02 ET | 1100 | 6.81 |
| 10:04 ET | 2100 | 6.88 |
| 10:06 ET | 9407 | 6.95 |
| 10:08 ET | 133 | 6.94 |
| 10:11 ET | 230 | 6.94 |
| 10:13 ET | 700 | 6.8375 |
| 10:15 ET | 730 | 6.9 |
| 10:20 ET | 4564 | 6.866 |
| 10:22 ET | 1000 | 6.8936 |
| 10:24 ET | 850 | 6.9657 |
| 10:26 ET | 1000 | 6.98 |
| 10:27 ET | 2855 | 6.9 |
| 10:29 ET | 100 | 6.96 |
| 10:31 ET | 530 | 6.9298 |
| 10:33 ET | 200 | 6.895 |
| 10:36 ET | 466 | 6.97 |
| 10:38 ET | 100 | 6.855 |
| 10:40 ET | 1800 | 6.81 |
| 10:44 ET | 1154 | 6.81 |
| 10:45 ET | 4459 | 6.8 |
| 10:49 ET | 3200 | 6.7852 |
| 10:51 ET | 100 | 6.77 |
| 10:54 ET | 300 | 6.79 |
| 11:00 ET | 150 | 6.7798 |
| 11:02 ET | 1139 | 6.825 |
| 11:05 ET | 1495 | 6.82 |
| 11:07 ET | 13690 | 6.755 |
| 11:16 ET | 320 | 6.74 |
| 11:25 ET | 100 | 6.73 |
| 11:32 ET | 250 | 6.7544 |
| 11:34 ET | 1934 | 6.77 |
| 11:36 ET | 2306 | 6.76 |
| 11:39 ET | 645 | 6.68 |
| 11:41 ET | 500 | 6.67 |
| 11:43 ET | 251 | 6.6976 |
| 11:45 ET | 1250 | 6.73 |
| 11:48 ET | 7240 | 6.73 |
| 11:50 ET | 800 | 6.7445 |
| 11:52 ET | 100 | 6.7333 |
| 11:54 ET | 1900 | 6.695 |
| 11:56 ET | 1209 | 6.67 |
| 11:57 ET | 295 | 6.6657 |
| 12:03 ET | 1311 | 6.695 |
| 12:06 ET | 2507 | 6.71 |
| 12:08 ET | 200 | 6.71 |
| 12:10 ET | 1300 | 6.74 |
| 12:12 ET | 2700 | 6.73 |
| 12:14 ET | 423 | 6.7301 |
| 12:15 ET | 500 | 6.71 |
| 12:17 ET | 700 | 6.73 |
| 12:24 ET | 140 | 6.765 |
| 12:28 ET | 100 | 6.7954 |
| 12:30 ET | 200 | 6.8 |
| 12:44 ET | 400 | 6.815 |
| 12:46 ET | 100 | 6.81 |
| 12:48 ET | 641 | 6.84 |
| 12:50 ET | 400 | 6.8109 |
| 12:51 ET | 747 | 6.83 |
| 12:53 ET | 412 | 6.76 |
| 12:55 ET | 1314 | 6.73 |
| 01:02 ET | 100 | 6.75 |
| 01:04 ET | 100 | 6.725 |
| 01:06 ET | 102 | 6.75 |
| 01:08 ET | 100 | 6.74 |
| 01:11 ET | 1200 | 6.75 |
| 01:15 ET | 1850 | 6.75 |
| 01:18 ET | 300 | 6.725 |
| 01:22 ET | 100 | 6.75 |
| 01:24 ET | 200 | 6.6924 |
| 01:26 ET | 215 | 6.6915 |
| 01:29 ET | 500 | 6.715 |
| 01:31 ET | 471 | 6.74 |
| 01:38 ET | 800 | 6.7398 |
| 01:44 ET | 100 | 6.73 |
| 01:45 ET | 170 | 6.7069 |
| 01:51 ET | 100 | 6.73 |
| 01:54 ET | 300 | 6.69 |
| 01:56 ET | 8266 | 6.658 |
| 02:02 ET | 200 | 6.6646 |
| 02:03 ET | 100 | 6.65 |
| 02:05 ET | 1000 | 6.63 |
| 02:07 ET | 185 | 6.6 |
| 02:12 ET | 200 | 6.56 |
| 02:16 ET | 1153 | 6.575 |
| 02:20 ET | 1048 | 6.58 |
| 02:27 ET | 1500 | 6.5842 |
| 02:30 ET | 1250 | 6.555 |
| 02:32 ET | 1977 | 6.5101 |
| 02:34 ET | 2573 | 6.53 |
| 02:36 ET | 150 | 6.5387 |
| 02:38 ET | 100 | 6.52 |
| 02:43 ET | 1207 | 6.5257 |
| 02:45 ET | 300 | 6.52 |
| 02:50 ET | 800 | 6.5 |
| 02:52 ET | 100 | 6.5 |
| 02:56 ET | 100 | 6.515 |
| 02:57 ET | 100 | 6.5153 |
| 02:59 ET | 700 | 6.5 |
| 03:01 ET | 1700 | 6.51 |
| 03:03 ET | 200 | 6.5 |
| 03:06 ET | 660 | 6.52 |
| 03:10 ET | 668 | 6.525 |
| 03:12 ET | 1340 | 6.529 |
| 03:17 ET | 100 | 6.5341 |
| 03:19 ET | 2253 | 6.495 |
| 03:21 ET | 482 | 6.415 |
| 03:24 ET | 100 | 6.425 |
| 03:26 ET | 357 | 6.41 |
| 03:28 ET | 665 | 6.43 |
| 03:32 ET | 400 | 6.43 |
| 03:35 ET | 2263 | 6.45 |
| 03:39 ET | 400 | 6.435 |
| 03:44 ET | 400 | 6.43 |
| 03:48 ET | 1050 | 6.43 |
| 03:50 ET | 100 | 6.415 |
| 03:51 ET | 3939 | 6.44 |
| 03:53 ET | 1300 | 6.48 |
| 03:55 ET | 1490 | 6.485 |
| 03:57 ET | 2546 | 6.49 |
| 04:00 ET | 6854 | 6.5 |
Yesterday
Nov 15, 2024
Nov 4, 2024
Precision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update, from 7:01AM ET on Monday Nov 04, 2024 by Dow Jones
7:01AM ET on Monday Nov 04, 2024 by Dow Jones*DJ Precision Biosciences 3Q Loss/Shr $2.25 >DTIL, from 7:01AM ET on Monday Nov 04, 2024 by Dow Jones
7:01AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 29, 2024
Press Release: Precision BioSciences to Report Third Quarter Results on November 4, 2024, from 7:05AM ET on Tuesday Oct 29, 2024 by Dow Jones
7:05AM ET on Tuesday Oct 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Precision BioSciences Inc | 55.1M | 8.5x | --- |
Champions Oncology Inc | 58.7M | -16.8x | --- |
Metagenomi Inc | 61.8M | -0.7x | --- |
RVL Pharmaceuticals PLC | 110.0 | 0.0x | --- |
Pieris Pharmaceuticals Inc | 21.1M | -1.3x | --- |
Repare Therapeutics Inc | 120.7M | -1.5x | --- |
Company Information
Precision BioSciences, Inc. is an advanced gene editing company dedicated to improving life (DTIL) with its proprietary ARCUS genome editing platform. Using ARCUS, the Company's pipeline consists of in vivo gene editing candidates designed to deliver cures for a range of genetic and infectious diseases. The ARCUS platform develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision. ARCUS particularly generates defined outcomes due to predominant repair using homology directed repair (HDR) as opposed to non-homologous end joining (NHEJ). The Company’s in vivo gene editing programs include PBGENE-HBV, PBGENE-PMM, PBGENE-NVS, PBGENE-DMD, PBGENE-LL2, PBGENE-LL3 and iECURE-OTC. PBGENE-HBV program is designed for the potential treatment of chronic hepatitis B virus (HBV). The Company is pursuing development of PBGENE-PMM as a potential opportunity for treatment of m.3243 associated primary mitochondrial myopathy (PMM).
Contact Information
- Headquarters
- 302 E Pettigrew St Ste A100DURHAM, NC, United States 27701-2393
- Phone
- 919-314-5512
- Fax
- 480-393-5553
Executives
- Independent Chairman of the Board
- Kevin Buehler
- President, Chief Executive Officer, Director
- Michael Amoroso
- Interim Chief Financial Officer
- Alex Kelly
- General Counsel, Secretary
- Dario Scimeca
- Chief Research Officer
- Jeff Smith
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $49.9M |
|---|---|
Revenue (TTM) | $75.1M |
Shares Outstanding | 7.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.40 |
EPS | $0.76 |
Book Value | $4.53 |
P/E Ratio | 8.5x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | 3.2x |
Operating Margin | -21.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
